The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(5,7-dichloro-2-(4-chlorobenzoyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(4-(methylsulfonyl)phenyl)propanoic acid ID: ALA2048027
Cas Number: 1355247-29-8
PubChem CID: 62705405
Max Phase: Preclinical
Molecular Formula: C27H23Cl3N2O6S
Molecular Weight: 609.91
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CS(=O)(=O)c1ccc(C[C@H](NC(=O)c2c(Cl)cc3c(c2Cl)CCN(C(=O)c2ccc(Cl)cc2)C3)C(=O)O)cc1
Standard InChI: InChI=1S/C27H23Cl3N2O6S/c1-39(37,38)19-8-2-15(3-9-19)12-22(27(35)36)31-25(33)23-21(29)13-17-14-32(11-10-20(17)24(23)30)26(34)16-4-6-18(28)7-5-16/h2-9,13,22H,10-12,14H2,1H3,(H,31,33)(H,35,36)/t22-/m0/s1
Standard InChI Key: YAPIRWIJBXRQKZ-QFIPXVFZSA-N
Molfile:
RDKit 2D
39 42 0 0 0 0 0 0 0 0999 V2000
4.9373 2.8355 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3539 2.1188 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.7662 2.8380 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3588 -2.0130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3576 -1.5997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3547 -0.7692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3607 -0.3600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0737 -1.6002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0741 -0.7727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7869 -0.3617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5038 -0.7735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5034 -1.6009 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7860 -2.0165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2181 -2.0130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9324 -1.6002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2185 -2.8380 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9280 -0.7764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6414 -0.3636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3571 -0.7758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3548 -1.6051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6408 -2.0141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0719 -0.3639 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-0.3627 0.4650 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.0727 -2.0111 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.0676 -0.3540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7837 -0.7638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0645 0.4710 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4966 -0.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4991 0.4776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2126 -0.7584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2157 -1.5834 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9255 -0.3432 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2148 0.8879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9248 0.4690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6400 0.8787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6429 1.7046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9247 2.1191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2124 1.7070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0719 1.7022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
8 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 9 1 0
8 9 2 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 1 0
14 15 1 0
14 16 2 0
15 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 15 1 0
19 22 1 0
7 23 1 0
5 24 1 0
6 25 1 0
25 26 1 0
25 27 2 0
26 28 1 0
28 29 1 1
28 30 1 0
30 31 1 0
30 32 2 0
29 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 37 1 0
37 38 2 0
38 33 1 0
36 2 1 0
2 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 609.91Molecular Weight (Monoisotopic): 608.0342AlogP: 4.67#Rotatable Bonds: 7Polar Surface Area: 120.85Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.27CX Basic pKa: ┄CX LogP: 4.47CX LogD: 1.03Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.40Np Likeness Score: -0.98
References 1. Zhong M, Gadek TR, Bui M, Shen W, Burnier J, Barr KJ, Hanan EJ, Oslob JD, Yu CH, Zhu J, Arkin MR, Evanchik MJ, Flanagan WM, Hoch U, Hyde J, Prabhu S, Silverman JA, Wright J.. (2012) Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye., 3 (3): [PMID:24900456 ] [10.1021/ml2002482 ]